Search

everythinglearnresearchcommunity

for

Search:↓

SFRP2 boosts Wnt3a/β-catenin signals in hair growth cells, with stronger effects in beard cells than scalp cells.

Increased 14-3-3 proteins may block hair cycle regression, causing hair loss.

Cantú syndrome may be linked to pituitary adenomas.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Low-penetration genes might help personalize colorectal cancer prevention.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

The research found that specific stem cells maintain skin gland openings and that disrupting their activity can cause blockages or early cancer signs, indicating a need for targeted treatments.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

TCHHL1 is a protein important for hair growth, found in hair follicles.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Certain gene variations may increase the risk and severity of alopecia areata.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Impaired LEF1 activation speeds up skin cell development in Hutchinson-Gilford Progeria Syndrome.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

SP1 promotes and KROX20 inhibits hair cell growth by affecting the CUX1 gene.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.